James S. Kuo is an entrepreneur and businessperson who founded Windtree Therapeutics, Inc., BioMicro Systems, Inc. and Monarch Labs, Inc. and who has been at the head of 13 different companies. Currently, he occupies the position of Chairman at ImmunoPrecise Antibodies Ltd., Non-Executive Chairman for MSK Pharma LLC, Chairman & Chief Executive Officer of KMRB Acquisition Corp. II, Chairman & Managing Director at Athena Bioventures, Inc, Chairman & Chief Executive Officer at ApoLife, Inc. and Chief Executive Officer & Director at Tryp Therapeutics, Inc. Dr. Kuo is also on the board of Monarch Labs, Inc.

In the past James S. Kuo occupied the position of Chairman & Chief Executive Officer for Cysteine Pharma, Inc., Non-Executive Chairman of Soligenix, Inc., Chief Executive Officer for OncoTracker, Inc., President & Chief Executive Officer at Windtree Therapeutics, Inc., Chief Executive Officer & IR Contact at FIT Biotech Oy, Director at Cordex Pharma, Inc., Managing Director-Venture Analysis at HealthCare Ventures LLC, Associate Director-Corporate Licensing at Pfizer Inc., Vice President-Business Development of Myriad Genetics, Inc. and Chairman & Chief Executive Officer at BioMicro Systems, Inc.

James S. Kuo received an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Perelman School of Medicine.